Recent Posts

RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potent…

RT @ThomasCiullaMD: Just co-authored this paper on integrin inhibition, a potentially important pathway for treatment of common causes of v… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phas…

RT @PharmacDaily: Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspen… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to …


RT @ThomasCiullaMD: Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #ma…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health reside…

RT @ThomasCiullaMD: I have great fun & satisfaction mentoring @IU_Health residents interested in #research. Congrats to this fantastic IU… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published…Understanding the #genetic basis for this c…

RT @ThomasCiullaMD: Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection… Source by Thomas Ciulla, MD, MBA Return to main website.

Just published-With clinical trials from small molecules to #genetherapy to vira…


Just published-With clinical trials from small molecules to #genetherapy to viral nanoparticles, for disorders from #macular edema to #AMD to #diabeticretinopathy to choroidal melanoma, an understanding of #suprachoroidal drug delivery becomes essential… https://t.co/4qIjnVZ9RP


Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published…Understanding the #genetic basis for this common cause of #visi…

Just published…Understanding the #genetic basis for this common cause of #vision loss will facilitate early detection, prognosis & treatment, perhaps even a #PrecisionMedicine approach like #gene therapy someday: #eyes #glaucoma #Ophthalmology #biotech https://t.co/1REz7x85tQ Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Honored to present on Suprachoroidal Drug Delivery & Clearsi…

RT @ThomasCiullaMD: Honored to present on Suprachoroidal Drug Delivery & Clearside’s preclinical and clinical research programs at the rece… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published on suprachoroidal drug delivery: “Clinical Ch…


RT @ThomasCiullaMD: Just published on suprachoroidal drug delivery: “Clinical Characterization of Suprachoroidal Injection Procedure Utiliz…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Honored to be listed here and thankful for those patients, c…

RT @ThomasCiullaMD: Honored to be listed here and thankful for those patients, colleagues & mentors who inspire us… Source by Thomas Ciulla, MD, MBA Return to main website.